Sex Differences in Social Behaviour in a Mouse Model of Aromatase Deficiency: An Autism Spectrum Disorder-Like Phenotype
thesis
posted on 2017-03-23, 03:18authored byKristina Vacy
Deficits in social
interaction, communication and repetitive behaviours are the core markers of
the autism spectrum disorders (ASD), which are five times more likely to be
diagnosed in boys than girls, reason unknown. Post-mortem studies showed that
ASD brains expressed less brain aromatase, and 15% fewer neurons in the
amygdala. Functional MRI showed a reduction in amygdala activity during social
processing tasks and this same region expressed abundant levels of aromatase,
the enzyme that catalyzes the conversion of androgens to oestrogens.
Our lab demonstrated that mouse posterodorsal medial amygdala
(PDMeA) contains high levels of aromatase, with males expressing more than
females. We hypothesized that male, but not female aromatase knockout (ArKO)
mouse, will exhibit behaviours consistent with a mouse model of ASD and that
administration of carbetocin (an analogue of oxytocin) will rescue the social
interaction deficit in the male ArKO.
Our aim was to analyse the social interaction behavior of the
oestrogen-deficient (ArKO) model and test whether carbetocin administration
could reverse any social interaction deficit.
The three chamber social interaction task was used to examine
social approach in three week-old male and female ArKO and Wildtype mice
littermates (WT). The effects of carbetocin treatment (2mg/kg and 20mg/kg i.p.)
on social behaviour was investigated in both juvenile and adult male mice using
this task. We found that male, but not female ArKO mice spent less time
interacting with sex and aged matched unfamiliar mice (a “ stranger”) compared
with WT of the same sex (n=6-10/group, p<0.05) during the social
approach trial. In a later experiment, we injected six month-old male ArKO and
WT intraperitoneally with 2mg/kg or 20mg/kg carbetocin but neither dose
increased social approach. We also recorded and analysed the ultrasonic
vocalizations (USV) made by male and female ArKO pups and WT littermates at
post-natal day 9 during a 5 min separation from the litter. Male but not female
ArKO pups made fewer and shorter USV (n=7-15/group, p<0.05).
As seizure disorders are more common in ASD, we tested
seizure susceptibility in 40-60 day old male ArKO and WT mice by subcutaneously
administering 80mg/kg of the pro-convulsant drug pentylenetetrazol (PTZ). We
then recorded time taken to reach the clonic and hind leg extension stages of
the resulting seizure and found a trend for the ArKO to reach the hind leg
extension stage more quickly compared to WT.
To measure neural activation of the PDMeA during social
interaction, we exposed 3 week-old male and female transgenic mice with a
Enhanced Fluorescent Green Protein reporter linked to the aromatase to a
stranger or a novel object. Their brains were harvested for immunohistochemical
analysis two hours after testing, and were co-labeled with c-fos, a marker for
neural activation, and GFP. We found greater c-fos immunoreactivity in mice
exposed to the stranger compared with object, thus we also exposed 3
week-oldmale ArKO to a stranger. Stereology analysis revealed significantly
more c-fos immunoreactivity in the ArKO compared with WT (N=4-5/group,
p<0.05).
Our results revealed behavioural sex differences between
genotypes, with male (but not female) ArKO mice showing a behavioural phenotype
consistent with ASD. These inferred that aromatase may play a role in
regulating ASD-like behaviour in a sex specific manner. However the addition of
the oxytocin analogue carbetocin did not rescue the social interaction deficit
of the male ArKO.